Literature DB >> 7792207

Carcinoid tumour complicating inflammatory bowel disease. A study of two cases with review of the literature.

F Le Marc'hadour1, F Bost, M Peoc'h, J J Roux, D Pasquier, B Pasquier.   

Abstract

Two cases of carcinoid tumour complicating inflammatory bowel disease (IBD) are presented. Both tumours were located in the appendiceal tip. The first case occurred in a man with Crohn's disease (CD), and the second one in a woman suffering from ulcerative colitis (UC). Histochemical and immunohistochemical studies were not allowed on case 1 because the tumour was not still present on serial sections of the appendix. On case 2, tumour cells were not reactive with Grimelius and Masson-Fontana stainings, but were strongly stained with anti-keratin and anti-chromogranin monoclonal antibodies (MAb), and faintly expressed neuron specific enolase (NSE), and Leu-7. Both cases occurred in inflammatory or damaged mucosa which exhibited Paneth cell metaplasia and hyperplasia and areas indefinite for dysplasia. Along with these lesions, hyperplasia of enteroendocrine cells was pointed out in the neighbouring appendiceal and colonic mucosa by means of anti-chromogranin MAb. These data suggest that the association of carcinoid tumour with IBD, albeit rare, is not coincidental and is the result of hyperplastic and dysplastic troubles that may involve enteroendocrine cells as well as such other derivatives of digestive stem cells as columnar cells, goblet cells and Paneth cells.

Entities:  

Mesh:

Year:  1994        PMID: 7792207     DOI: 10.1016/S0344-0338(11)80445-0

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  7 in total

1.  Multiple microcarcinoids in a patient with long standing ulcerative colitis.

Authors:  T Matsumoto; Y Jo; R Mibu; M Hirahashi; T Yao; M Iida
Journal:  J Clin Pathol       Date:  2003-12       Impact factor: 3.411

2.  Genetic polymorphisms of interleukin 1β gene and sporadic pancreatic neuroendocrine tumors susceptibility.

Authors:  Dimitrios Karakaxas; Anna Sioziou; Gerasimos Aravantinos; Ahmet Coker; Ioannis S Papanikolaou; Theodoros Liakakos; Christos Dervenis; Maria Gazouli
Journal:  World J Gastrointest Oncol       Date:  2016-06-15

3.  Epidemiology of Large Bowel Carcinoid Tumors in the USA: A Population-Based National Study.

Authors:  Pooja Lal; Mohannad Abou Saleh; George Khoudari; Mohamed M Gad; Emad Mansoor; Gerard Isenberg; Gregory S Cooper
Journal:  Dig Dis Sci       Date:  2019-07-12       Impact factor: 3.199

4.  A "false positive" octreoscan in ileal Crohn's disease.

Authors:  Alberto Fernandez; Olga Tabuenca; Angeles Peteiro
Journal:  World J Gastroenterol       Date:  2008-09-14       Impact factor: 5.742

5.  Pretreatment hematologic markers as prognostic predictors of gastroenteropancreatic neuroendocrine tumors: a systematic review and meta-analysis.

Authors:  Yu Zhou; Dezhi Li; Ye Lin; Min Yu; Xin Lu; Zhixiang Jian; Ning Na; Baohua Hou
Journal:  Onco Targets Ther       Date:  2018-05-01       Impact factor: 4.147

6.  Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors.

Authors:  Tal Grenader; Marianne E Pavel; Philippe B Ruszniewski; Jarosław B Ćwikła; Alexandria T Phan; Markus Raderer; Eva Sedláčková; Guillaume Cadiot; Edward M Wolin; Jaume Capdevila; Lucy Wall; Guido Rindi; Xuan-Mai Truong Thanh; Martyn E Caplin
Journal:  Anticancer Drugs       Date:  2020-03       Impact factor: 2.389

Review 7.  Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?

Authors:  Elisa Giannetta; Anna La Salvia; Laura Rizza; Giovanna Muscogiuri; Severo Campione; Carlotta Pozza; Annamaria Anita LIvia Colao; Antongiulio Faggiano
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-22       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.